Emmanuel Dulac appointed CEO
Zealand’s new Chief Executive Officer will begin April 22, 2019. Read more
Annual General Meeting 2019
The Annual General Meeting for 2019 was on Thursday, April 4, 2019. Read more
Applying our peptide platform to specialty disease areas to invent novel therapies.
Advancing fully owned development programs with Phase 3 in two rare disease programs. See our pipeline